Editas Medicine to Present New Data Demonstrating Progress Towards Creating Genome Editing Medicines at the …NasdaqAs a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cp… Continue reading
Editas Medicine to Present New Data Demonstrating Progress Towards Creating Genome Editing Medicines at the …NasdaqAs a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cp… Continue reading
Editas Medicine to Present New Data Demonstrating Progress Towards Creating Genome Editing Medicines at the …GlobeNewswire (press release)As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the … Continue reading
|
Sponsor: MD Anderson at forefront of immunotherapy cancer treatment
Chron.com Immunotherapy is an innovative new approach to cancer treatment that uses the body’s own natural defenses to fight the disease. While immunotherapy offers great promise to patients and has produced great results, it is still in clinical trials. Because … |
|
CRISPR Work Ahead
GenomeWeb While researchers are excited about the potential of gene-editing tool CRISPR and how it could be used to treat or prevent disease, they tell CBS News’ 60 Minutes that more work needs to be done. “There are about 6,000 or more diseases that are caused … |